Aldeyra Therapeutics (ALDX) Other Accumulated Expenses (2014 - 2015)
Aldeyra Therapeutics (ALDX) posted Other Accumulated Expenses of $48657.0 for Q4 2015, down 60.33% on a QoQ basis from $122664.0 in Q3 2015, and little changed year-over-year from $48839.0 in Q4 2014.
Aldeyra Therapeutics (ALDX) Other Accumulated Expenses (2014 - 2015) Analysis & Trends
Aldeyra Therapeutics' Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $48657.0 for Q4 2015.
- Quarterly Other Accumulated Expenses changed 0.37% year-over-year to $48657.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $48657.0 (changed 0.37% YoY) and the FY2015 annual result came in at $48657.0, changed 0.37% from the prior year.
- Other Accumulated Expenses was $48657.0 for Q4 2015 at Aldeyra Therapeutics, down from $122664.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $122664.0 in Q3 2015 and bottomed at $48657.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn |
| 10 | Aldeyra Therapeutics | 93.49 Mn | 93.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 48,657.00 |
| Sep 30, 2015 | 122,664.00 |
| Dec 31, 2014 | 48,839.00 |